Clinical Characteristics and Survival Outcomes for Non-Small-Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Double Mutations

Multiple randomized clinical trials have demonstrated that epidermal growth factor receptor (EGFR) exon 19 deletion (19Del) and exon 21 L858R mutation (L858R) are highly correlated with sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in non-small-cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Min, Weng, Yi Ming, Liu, Hua Li, Yang, Gui Fang, Yao, Yi, Han, Guang, Song, Qi Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822926/
https://www.ncbi.nlm.nih.gov/pubmed/29581983
http://dx.doi.org/10.1155/2018/7181368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822926/
https://www.ncbi.nlm.nih.gov/pubmed/29581983
http://dx.doi.org/10.1155/2018/7181368

Ejemplares similares